Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2328314 | 1.00 | ACE (0.49) | ACESMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL8948036 | 1.00 | ACE (0.49) | ACESMN1; SMN2MEN1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL27733929 | 0.98 | ACE (0.48) | ACESMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL6051729 | 0.87 | SMN1; SMN2 (0.45) | ACESMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL1031027 | 0.84 | CPA3 (0.50) | — | |
| SCHEMBL1109641 | 0.84 | CPA3 (0.50) | — | |
| SCHEMBL515921 | 0.84 | CPA3 (0.50) | — | |
| SCHEMBL5505220 | 0.83 | MME (0.49) | ACELMNAFFAR1 | |
| SCHEMBL1760830 | 0.83 | ALDH1A1 (0.50) | ACESMN1; SMN2KMT2ALMNANPC1 | |
| SCHEMBL29597658 | 0.83 | ALDH1A1 (0.50) | ACESMN1; SMN2KMT2ALMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-26 | — | — | US | claimed |
| EP-4493273-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | Politechnika Wroclawska (PL) | 2025-01-22 | — | — | EP | claimed |
| WO-2023175356-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | POLITECHNIKA WROCLAWSKA (PL) | 2023-09-21 | — | — | WO | claimed |
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-26 | — | — | US | disclosed |
| EP-4493273-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | Politechnika Wroclawska (PL) | 2025-01-22 | — | — | EP | disclosed |
| WO-2023175356-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | POLITECHNIKA WROCLAWSKA (PL) | 2023-09-21 | — | — | WO | disclosed |
| EP-0497368-B1 | CNP analog peptides and their use | SUNTORY LTD (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-5571683-A | HEMOCYTE LYSATE WITH ENDOTOXIN NEUTRALIZING PEPTIDES | MARUHA CORPORATION (JP) | 1996-11-05 | — | — | US | disclosed |
| EP-0549102-B1 | Beta-glucans detection reagents and methods of detecting beta-glucans | MARUHA CORP (JP) | 1996-07-03 | — | — | EP | disclosed |
| US-5486596-A | CYCLIC PEPTIDES | CESKOSLOVENSKA AKADEMIE VED (CS) | 1996-01-23 | — | — | US | disclosed |
| US-5434133-A | C-type naturiuretic peptide, suppress vascular smooth muscle cell growth | SUNTORY LIMITED (JP) | 1995-07-18 | — | — | US | disclosed |
| EP-0549102-A1 | Beta-glucans detection reagents and methods of detecting beta-glucans | MARUHA CORPORATION (JP) | 1993-06-30 | — | — | EP | disclosed |
| EP-0497368-A1 | CNP analog peptides and their use | SUNTORY LIMITED (JP) | 1992-08-05 | — | — | EP | disclosed |
| EP-0231728-B1 | SYNTHETIC PEPTIDE WITH HUMAN INTERLEUKIN 1 ACTIVITY | SCLAVO S.p.A. (IT) | 1991-05-22 | — | — | EP | disclosed |
| EP-0112149-B1 | MOLECULAR CLONING AND CHARACTERIZATION OF A FURTHER GENE SEQUENCE CODING FOR HUMAN RELAXIN | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1991-04-10 | — | — | EP | disclosed |
| EP-0391999-A4 | PEPTIDYL INHIBITORS OF THE INITIATION OF COAGULATION | — | 1991-03-13 | — | — | EP | disclosed |
| EP-0391999-A1 | PEPTIDYL INHIBITORS OF THE INITIATION OF COAGULATION | CORVAS, INC. (US) | 1990-10-17 | — | — | EP | disclosed |
| WO-1990003390-A1 | PEPTIDYL INHIBITORS OF THE INITIATION OF COAGULATION | CORVAS, INC. (US) | 1990-04-05 | — | — | WO | disclosed |
| US-4774320-A | IMMUNOLOGY | SCLAVO S.P.A. (IT) | 1988-09-27 | — | — | US | disclosed |
| EP-0231728-A2 | Synthetic peptide with human interleukin 1 activity | SCLAVO S.p.A. (IT) | 1987-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | F11, F2, F12 | ACE 289/4885SMN1; SMN2 3707/4885MEN1 518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.